China Resources Double-Crane Pharmaceutical Co Ltd

SHG:600062 China Drug Manufacturers - Specialty & Generic
Market Cap
$2.58 Billion
CN¥18.93 Billion CNY
Market Cap Rank
#4315 Global
#425 in China
Share Price
CN¥18.22
Change (1 day)
-0.05%
52-Week Range
CN¥17.63 - CN¥21.22
All Time High
CN¥33.06
About

China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People's Republic of China. The company offers pharmaceutical products for blood pressure, blood sugar, injection, lipid-lowering, pediatrics, nephrology, API, pharmaceutical, psychiatry/neurology, anticoagulation, oncology, women's health, anesthesia, and analgesia. The company was founded in 1939 an… Read more

China Resources Double-Crane Pharmaceutical Co Ltd (600062) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: 0.040x

Based on the latest financial reports, China Resources Double-Crane Pharmaceutical Co Ltd (600062) has a cash flow conversion efficiency ratio of 0.040x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥487.90 Million) by net assets (CN¥12.16 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

China Resources Double-Crane Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how China Resources Double-Crane Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

China Resources Double-Crane Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of China Resources Double-Crane Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for China Resources Double-Crane Pharmaceutical Co Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of China Resources Double-Crane Pharmaceutical Co Ltd from 1998 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥11.11 Billion CN¥1.83 Billion 0.164x +17.31%
2023-12-31 CN¥11.79 Billion CN¥1.65 Billion 0.140x +11.98%
2022-12-31 CN¥10.73 Billion CN¥1.34 Billion 0.125x -2.30%
2021-12-31 CN¥10.48 Billion CN¥1.34 Billion 0.128x -11.76%
2020-12-31 CN¥9.38 Billion CN¥1.36 Billion 0.145x -12.59%
2019-12-31 CN¥8.68 Billion CN¥1.44 Billion 0.166x -10.67%
2018-12-31 CN¥7.91 Billion CN¥1.47 Billion 0.186x +22.81%
2017-12-31 CN¥7.85 Billion CN¥1.19 Billion 0.151x +38.03%
2016-12-31 CN¥7.04 Billion CN¥771.25 Million 0.110x +0.52%
2015-12-31 CN¥6.43 Billion CN¥701.35 Million 0.109x -13.74%
2014-12-31 CN¥5.68 Billion CN¥718.38 Million 0.126x +23.46%
2013-12-31 CN¥5.34 Billion CN¥546.24 Million 0.102x +21.65%
2012-12-31 CN¥4.71 Billion CN¥396.05 Million 0.084x -28.55%
2011-12-31 CN¥4.34 Billion CN¥511.53 Million 0.118x -9.28%
2010-12-31 CN¥3.93 Billion CN¥509.67 Million 0.130x +34.17%
2009-12-31 CN¥3.53 Billion CN¥342.01 Million 0.097x -8.10%
2008-12-31 CN¥3.15 Billion CN¥331.71 Million 0.105x +5.74%
2007-12-31 CN¥2.36 Billion CN¥235.46 Million 0.100x -34.59%
2006-12-31 CN¥2.00 Billion CN¥303.71 Million 0.152x +111.19%
2005-12-31 CN¥1.94 Billion CN¥139.78 Million 0.072x -72.56%
2004-12-31 CN¥1.73 Billion CN¥453.72 Million 0.263x +202.75%
2003-12-31 CN¥1.72 Billion CN¥148.94 Million 0.087x -0.99%
2002-12-31 CN¥1.60 Billion CN¥140.63 Million 0.088x -7.41%
2001-12-31 CN¥1.49 Billion CN¥141.01 Million 0.095x -53.16%
2000-12-31 CN¥855.27 Million CN¥172.81 Million 0.202x +9.25%
1999-12-31 CN¥711.23 Million CN¥131.54 Million 0.185x +826.55%
1998-12-31 CN¥541.45 Million CN¥-13.78 Million -0.025x --